Table 2.
Anatomical site | Groups in studies (N) | ED (N) | HC (N) | SMD | L 95% CI | U 95% CI | Z | p | I2 (%) | Egger | p |
---|---|---|---|---|---|---|---|---|---|---|---|
All studies | |||||||||||
Total body BMD | 32 | 996 | 963 | − 2.62 | − 3.39 | − 1.84 | 6.59 | < 0.001 | 99.2 | − 5.76 | < 0.001 |
Spine BMD | 49 | 1941 | 2299 | − 3.31 | − 3.98 | − 2.63 | 9.61 | < 0.001 | 99.4 | − 6.87 | < 0.001 |
Femur BMD | 24 | 894 | 1051 | − 3.08 | − 4.33 | − 1.83 | 4.82 | < 0.001 | 98.7 | − 5.03 | < 0.001 |
AN | |||||||||||
Total body BMD | 24 | 683 | 676 | − 3.45 | − 4.57 | − 2.33 | 6.04 | < 0.001 | 99.1 | ||
Spine BMD | 36 | 1553 | 1743 | − 4.34 | − 5.27 | − 3.40 | 9.11 | < 0.001 | 99.4 | ||
Femur BMD | 20 | 788 | 954 | − 3.38 | − 5.30 | − 2.22 | 4.78 | < 0.001 | 98.8 | ||
Hip BMD | 19 | 1078 | 688 | − 4.95 | − 6.78 | − 3.12 | 5.30 | < 0.001 | 98.9 | − 2.52 | 0.012 |
BN | |||||||||||
Total body BMD | 7 | 291 | 253 | − 0.29 | − 0.46 | − 0.12 | 3.27 | 0.001 | 4.8 | ||
Spine BMD | 12 | 366 | 522 | − 0.49 | − 0.77 | − 0.21 | 3.45 | 0.001 | 63.7 | ||
Femur BMD | 3 | 84 | 63 | − 0.19 | − 0.80 | − 0.43 | 0.60 | 0.552 | 66.6 | ||
BN with history of AN | |||||||||||
Spine BMD | 4 | 67 | 21 | − 0.74 | − 1.06 | − 0.43 | 4.58 | < 0.001 | 0 | ||
BN without history of AN | |||||||||||
Spine BMD | 2 | 85 | 96 | − 0.07 | − 1.05 | − 0.90 | 0.14 | 0.885 | 89.7 | ||
OSFED/EDNOS only | |||||||||||
Total body BMD | 1 | 22 | 34 | − 0.04 | − 0.99 | 0.10 | 1.60 | 0.109 | |||
Spine BMD | 1 | 22 | 34 | − 2.44 | − 3.15 | − 1.73 | 6.77 | < 0.001 | |||
Femur BMD | 1 | 22 | 34 | − 0.24 | − 0.76 | 0.31 | 0.82 | 0.415 |
P-value in bold indicates statistical significance (p < 0.05)
N sample number, ED eating disorder, HC healthy control, SMD standardised mean difference, L lower, U upper, CI confidence interval, Z z-scores, p p value, BMD bone mineral density, AN anorexia nervosa, BN bulimia nervosa, OSFED other specified feeding or eating disorder, EDNOS Eating disorder not otherwise specified, I2 Higgins I2 test